Author:
Soff Gerald,Leader Avi,Al-Samkari Hanny,Falanga Anna,Maraveyas Anthony,Sanfilippo Kristen,Wang Tzu-Fei,Zwicker Jeffrey
Reference44 articles.
1. Hematopoietic Growth Factors. NCCN clinical practice guidelines in oncology (NCCN Guidelines®); 2023. https://www.nccn.org/professionals/physician_gls/pdf/growthfactors.pdf
2. Dose reductions and delays: limitations of myelosuppressive chemotherapy;Cairo;Oncology (Williston Park),2000
3. Occurrence and management of thrombocytopenia in metastatic colorectal cancer patients receiving chemotherapy: secondary analysis of data from prospective clinical trials;Kilpatrick;Clin Colorectal Cancer,2021
4. Managing thrombocytopenia associated with cancer chemotherapy;Kuter;Oncology (Williston Park),2015
5. Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia;Elting;J Clin Oncol,2001